Works matching IS 20050380 AND DT 2025 AND VI 36 AND IP 1
Results: 21
CHIPOR, HORSE, and beyond: unraveling the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e73
- By:
- Publication type:
- Article
Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e72
- By:
- Publication type:
- Article
Clinical practice guidelines for uterine corpus cancer: an update to the Korean Society of Gynecologic Oncology guidelines.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e71
- By:
- Publication type:
- Article
Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e70
- By:
- Publication type:
- Article
Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e69
- By:
- Publication type:
- Article
PRIMA: captivated by the wizard of OS?
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e55
- By:
- Publication type:
- Article
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-OV80).
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e51
- By:
- Publication type:
- Article
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e14
- By:
- Publication type:
- Article
Cancer-field surgery for endometrial cancer by robotic peritoneal mesometrial resection and targeted compartmental lymphadenectomy (PMMR+TCL).
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e13
- By:
- Publication type:
- Article
Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e12
- By:
- Publication type:
- Article
ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e11
- By:
- Publication type:
- Article
Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy in patients with locally advanced cervical squamous cell carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e10
- By:
- Publication type:
- Article
Para-aortic lymph node dissection with or without nerve-sparing in gynecological malignancies.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e9
- By:
- Publication type:
- Article
Prophylactic salpingectomy as a preventative strategy for ovarian cancer in the general population: a systematic review and meta-analysis.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e8
- By:
- Publication type:
- Article
Prevalence of high-risk human papillomavirus genotypes among women in Uzbekistan, 2021-2023.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e7
- By:
- Publication type:
- Article
Immunotherapy plus chemotherapy in patients with advanced endometrial cancer: a cost-effectiveness analysis.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e6
- By:
- Publication type:
- Article
Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e5
- By:
- Publication type:
- Article
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e4
- By:
- Publication type:
- Article
Prognostic impact of the number of resected pelvic nodes in endometrial cancer: Japanese Gynecologic Oncology Group Study JGOG2043 post hoc analysis.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e3
- By:
- Publication type:
- Article
Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e2
- By:
- Publication type:
- Article
Nomogram for predicting pathology upstaging in patients with EIN: is sentinel lymph node assessment useful in these patients?
- Published in:
- Journal of Gynecologic Oncology, 2025, v. 36, n. 1, p. 1, doi. 10.3802/jgo.2025.36.e1
- By:
- Publication type:
- Article